angiotensin II receptor blockers, eprosartan
DISEASE INTERVENTION COMPARISON RESULTS
Stroke. 2005 Jun;36(6):1218-26. Epub 2005 May 5 Randomized Controlled Trial, Multicenter Study
IN stroke, hypertension, primary The Use of
angiotensin II receptor blockers, eprosartan
As Treatment, Chronic
Is better Than
calcium antagonist, nitrendipine
To reduce a composite of total mortality and all cardiovascular and cerebrovascular events: 283 total events with sartan VS 366 with nitrendipine at 2.5 years.